Oncology Insights

A Catalyst Oncology Newsletter?

Welcome to the latest edition of Oncology Insights! We are thrilled to present you with our latest updates, including the recent activities and achievements of our experts.?

Optimizing Oncology Outcomes with Pharmacokinetics (PK)??

Let’s dive right in! Learn from Lydia King, Director, Biostatistics, Catalyst Oncology, and Craig McIlloney, Senior Vice President, Catalyst Flex, as they discuss the significance of pharmacokinetic (PK) data in advancing oncology therapeutics. Discover how Catalyst's comprehensive PK services can be tailored to address your specific needs.??

A Global Approach?

Continuing our Global Approach series, we introduced Ahmed Tariq. Ahmed has nearly four years of experience in contract research organizations. He is a vital member of the international Catalyst Oncology team. Ahmed enjoys that Catalyst Oncology provides him with opportunities to interact with multiple cultures. He feels that he is making a difference. Read more about Ahmed and Catalyst Oncology’s global approach.??

CTOEC Conference Highlights?

Last week our experts had the opportunity to participate at Clinical Trials in Oncology Series East Coast. ?

Keya Watkins, SVP, Catalyst Oncology, who served as the?conference chair, and Wei (Danny) Lu from BeiGene, engaged in "Deconstructing and Evolving the Role of the CRA to Better Suit the Needs of the Biotechs and CROs and Add Value to Safer, Stronger Clinical Trials," a fireside chat.?

On the following day, Kate Lai from Mythic Therapeutics and Troy DeSelms from Catalyst, presented "The Importance of Forging Strong Partnerships in Cancer Research."??

Navigating Trial Complexities with Adam Coleman?

Another one of our experts sharing insights is Adam Coleman, MSPAS, PA, Associate Director, Catalyst Oncology, who co-presented a breakout session at the Medidata Solutions NEXT Conference Series in Boston with Ann Koehler, Product Strategy Director, Medidata. The discussion revolved around current complexities in the clinical trial landscape, industry trends, and the use of data to address various challenges. To learn more, watch the full discussion here: https://lnkd.in/gmUBknpM?

Connect with Catalyst Oncology?

ESMO 2024 is just around the corner! Catalyst Oncology is thrilled we will be at booth #50 in Barcelona in September. Message us at [email protected]?to schedule time to connect with our team there.?